跳到主要导航 跳到搜索 跳到主要内容

Significance of resveratrol in clinical management of chronic diseases

  • Awais Wahab
  • , Kuo Gao
  • , Caixia Jia
  • , Feilong Zhang
  • , Guihua Tian
  • , Ghulam Murtaza
  • , Jianxin Chen*
  • *此作品的通讯作者
  • Beijing University of Chinese Medicine
  • COMSATS University Islamabad
  • CAS - Institute of Automation

科研成果: 期刊稿件 › 文献综述 › 同行评审

摘要

Resveratrol could be beneficial to health and provides protection against a wide array of pathologies and age-associated problems, as evident from preclinical studies. However, a comparison of animal and human studies reveals that this dietary polyphenol cannot protect against metabolic diseases and their associated complications. The clinical outcomes are affected by many factors such as sample size. This article not only presents a comprehensive review of the current advances concerning the dose, the extent of absorption, interaction and toxicity of resveratrol in human studies, but also describes its therapeutic effects against several chronic diseases such as diabetes mellitus, obesity, cardiovascular diseases, cancer and aging and the related diseases.

源语言英语
期刊论文编号1329
期刊Molecules
卷22
期8
DOI
出版状态已出版 - 8月 2017
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Significance of resveratrol in clinical management of chronic diseases' 的科研主题。它们共同构成独一无二的学术指纹。

引用此